[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

May 2020 - January 1920




May 2020, Vol 156, No. 5, Pages 488-604


JAMA Dermatology—The Year in Review, 2019

Abstract Full Text
free access
JAMA Dermatol. 2020;156(5):491-492. doi:10.1001/jamadermatol.2019.4076

Patient Perspectives on the Use of Artificial Intelligence

Abstract Full Text
JAMA Dermatol. 2020;156(5):493-494. doi:10.1001/jamadermatol.2019.5013

At the Leading Edge in Morphea—New Insights Into Disease Course and Management Options

Abstract Full Text
JAMA Dermatol. 2020;156(5):495-496. doi:10.1001/jamadermatol.2020.0033

Residency Education on Sexual and Gender Minority Health: Ensuring Culturally Competent Dermatologists and Excellent Patient Care

Abstract Full Text
JAMA Dermatol. 2020;156(5):497-499. doi:10.1001/jamadermatol.2020.0112
Original Investigation

Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening: A Qualitative Study

Abstract Full Text
has audio
JAMA Dermatol. 2020;156(5):501-512. doi:10.1001/jamadermatol.2019.5014

This qualitative study examines how the use of artificial intelligence as a screening tool is perceived by patients receiving care in a dermatology clinic.

Changes in Disease Activity and Damage Over Time in Patients With Morphea

Abstract Full Text
has audio
JAMA Dermatol. 2020;156(5):513-520. doi:10.1001/jamadermatol.2020.0034

This cohort study investigates the disease course in patients with morphea treated with standard-of-care therapy using validated clinical outcome measures.

Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea

Abstract Full Text
JAMA Dermatol. 2020;156(5):521-528. doi:10.1001/jamadermatol.2020.0035

This cohort study evaluates the use of mycophenolate mofetil and mycophenolic acid for the treatment of morphea.

Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy

Abstract Full Text
JAMA Dermatol. 2020;156(5):529-537. doi:10.1001/jamadermatol.2020.0218

This cohort study investigates the risks of skin cancer and premalignant skin lesions among patients with vitiligo undergoing narrowband UV-B phototherapy, based on the number of narrowband UV-B phototherapy sessions.

Evaluation of Point-of-Care Decision Support for Adult Acne Treatment by Primary Care Clinicians

Abstract Full Text
JAMA Dermatol. 2020;156(5):538-544. doi:10.1001/jamadermatol.2020.0135

This cohort study examines the association of the implementation of an algorithm-based, decision-support tool with changes in referral rates and treatment of adult acne among primary care clinicians.

Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial

Abstract Full Text
has active quiz
JAMA Dermatol. 2020;156(5):545-552. doi:10.1001/jamadermatol.2020.0290

This post hoc analysis of a randomized clinical trial examines factors associated with short-term relapse in patients with pemphigus treated with rituximab.

Evaluation of Sex-Specific Incidence of Melanoma

Abstract Full Text
JAMA Dermatol. 2020;156(5):553-560. doi:10.1001/jamadermatol.2020.0470

This cross-sectional study examines the incidence of melanoma in men vs women between differing geographic locations, ages, and anatomic sites.

Health Insurance Coverage of Permanent Hair Removal in Transgender and Gender-Minority Patients

Abstract Full Text
JAMA Dermatol. 2020;156(5):561-565. doi:10.1001/jamadermatol.2020.0480

This cross-sectional study examines coverage of permanent hair removal in transgender and gender-minority patients by marketplace and Medicaid health insurance policies and correlates the policies in each state with statewide protections of coverage for gender-affirming care.

Brief Report

Treatment of Childhood-Onset Lupus Erythematosus Panniculitis With Rituximab

Abstract Full Text
JAMA Dermatol. 2020;156(5):566-569. doi:10.1001/jamadermatol.2019.4984

This case series describes the clinical features of childhood-onset lupus erythematosus panniculitis and reports on the use of rituximab for patients with treatment-refractory, childhood-onset disease.

Association of Afamelanotide With Improved Outcomes in Patients With Erythropoietic Protoporphyria in Clinical Practice

Abstract Full Text
JAMA Dermatol. 2020;156(5):570-575. doi:10.1001/jamadermatol.2020.0352

This study evaluates time spent outside, number of phototoxic reactions, disease-specific quality of life, usage of protective clothing, and adverse events in patients treated with afamelanotide for erythropoietic protoporphyria.

Images in Dermatology

Linear Atrophoderma of Moulin

Abstract Full Text
JAMA Dermatol. 2020;156(5):581. doi:10.1001/jamadermatol.2020.0320

This case report describes an adolescent girl with brown, atrophic patches on the right arm, flank, and leg.

Eosinophilic Fasciitis

Abstract Full Text
JAMA Dermatol. 2020;156(5):582. doi:10.1001/jamadermatol.2020.0665

This case report describes a 20-year-old man with a 1-month history of skin induration and a prominent groove sign along the course of the forearm vein.

JAMA Dermatology Clinicopathological Challenge

Unilateral Atrophic Hyperpigmentation

Abstract Full Text
has active quiz
JAMA Dermatol. 2020;156(5):583-584. doi:10.1001/jamadermatol.2020.0069

A woman in her late 20s presented with an asymptomatic hyperpigmentation on the right side of the trunk, right upper arm, and right leg, strictly following the lines of Blaschko. What is your diagnosis?

A Solitary Scaly Plaque on the Lower Extremity of a Young Girl

Abstract Full Text
has active quiz
JAMA Dermatol. 2020;156(5):585-586. doi:10.1001/jamadermatol.2020.0059

A preschool-age girl presents with an asymptomatic plaque on the right lower extremity. Immunohistochemical staining was markedly positive for CD3, CD5, and CD8. What is your diagnosis?

Facial Erythema in an Elderly Man

Abstract Full Text
has active quiz
JAMA Dermatol. 2020;156(5):587-588. doi:10.1001/jamadermatol.2020.0123

A man in his 80s presented with asymmetric, centrofacial, erythematous-violaceous indurated telangiectatic and ecchymotic plaques over a phymatous background. What is your diagnosis?

Research Letter

Quality of Life in Patients With Skin of Color and Chronic Graft-vs-Host Disease

Abstract Full Text
JAMA Dermatol. 2020;156(5):589-590. doi:10.1001/jamadermatol.2019.4857

This survey study explores the scope of chronic graft-vs-host disease among a cohort of patients with skin of color.

A Cross-sectional Comparison of Magnetic Resonance Imaging Findings and Clinical Assessment in Patients With Morphea

Abstract Full Text
JAMA Dermatol. 2020;156(5):590-592. doi:10.1001/jamadermatol.2020.0036

This cross-sectional analysis compares clinical assessment with magnetic resonance imaging (MRI) findings in determining the extent of disease in patients with morphea.

Sexual and Gender Minority Curricula Within US Dermatology Residency Programs

Abstract Full Text
JAMA Dermatol. 2020;156(5):593-594. doi:10.1001/jamadermatol.2020.0113

This survey study assesses what health topics specific to sexual and gender minority patients are covered in dermatology residency programs to identify possible gaps and guide improvements.

Mycophenolate Mofetil for Eosinophilic Fasciitis: A Retrospective Analysis From 3 Tertiary Care Centers

Abstract Full Text
JAMA Dermatol. 2020;156(5):595-597. doi:10.1001/jamadermatol.2020.0120

This cohort study examines the clinical response outcomes of 14 patients with eosinophilic fasciitis treated with mycophenolate mofetil.


Co-occurrence of Merkel Cell Carcinoma and Chronic Inflammatory Demyelinating Polyneuropathy

Abstract Full Text
JAMA Dermatol. 2020;156(5):597-598. doi:10.1001/jamadermatol.2020.0055

This case report describes 2 men, each with an 8-year history of chronic inflammatory demyelinating polyneuropathy, who later developed Merkel cell carcinoma, and a third man who presented with Merkel cell carcinoma and, after completing treatment, was diagnosed as having chronic inflammatory demyelinating polyneuropathy.

Treatment of PD-1/PD-L1 Inhibitor–Induced Dermatitis Resolves Concomitant Eruptive Keratoacanthomas

Abstract Full Text
JAMA Dermatol. 2020;156(5):598-600. doi:10.1001/jamadermatol.2020.0176

This case report describes 3 patients, 2 men and 1 woman, with various forms of metastatic cancer who developed both dermatitis and keratoacanthomas after the initiation of immunotherapy.

Diffuse Telangiectatic Rash Associated With Novel Antibody Drug Conjugate Therapies

Abstract Full Text
JAMA Dermatol. 2020;156(5):601-603. doi:10.1001/jamadermatol.2020.0208

This case report describes 6 patients of varying ages who presented with a diffuse telangiectatic rash following treatment for lymphoma or metastatic neuroendocrine tumor.

Comment & Response

Endocrine-Disrupting Chemicals in Cosmetics

Abstract Full Text
JAMA Dermatol. 2020;156(5):603-604. doi:10.1001/jamadermatol.2020.0301

Endocrine-Disrupting Chemicals in Cosmetics—Reply

Abstract Full Text
JAMA Dermatol. 2020;156(5):604. doi:10.1001/jamadermatol.2019.4661

Error in Figure 1

Abstract Full Text
free access
JAMA Dermatol. 2020;156(5):604. doi:10.1001/jamadermatol.2020.1353
Peer Reviewers List

JAMA Dermatology Peer Reviewers in 2019

Abstract Full Text
free access online only
JAMA Dermatol. 2020;156(5):e200133. doi:10.1001/jamadermatol.2020.0133
JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2020;156(5):488. doi:10.1001/jamadermatol.2019.3015